DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair, With death on the horizon, nothing will not stop me except God................DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 25Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK GENERICS at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contribution
Showing posts with label Atorvastatin calcium. Show all posts
Showing posts with label Atorvastatin calcium. Show all posts

Saturday, 28 February 2015

Atorvastatin calcium


Atorvastatin calcium




1H NMR DMSOD6






13C NMR DMSOD6



.....................................

http://www.google.com/patents/EP0848705B1?cl=en

    SOLID STATE NUCLEAR MAGNETIC RESONANCE (NMR)Methodology
  • [0028]
    All solid-state 13C NMR measurements were made with a Bruker AX-250, 250 MHz NMR spectrometer. High resolution spectra were obtained using high-power proton decoupling and cross-polarization (CP) with magic-angle spinning (MAS) at approximately 5 kHz. The magic-angle was adjusted using the Br signal of KBr by detecting the side bands as described by Frye and Maciel (Frye J.S. and Maciel G.E., J. Mag. Res., 1982;48:125). Approximately 300 to 450 mg of sample packed into a canister-design rotor was used for each experiment. Chemical shifts were referenced to external tetrakis (trimethylsilyl)silane (methyl signal at 3.50 ppm) (Muntean J.V. and Stock L.M., J. Mag. Res., 1988;76:54).
  • [0029]
    Table 2 shows the solid-state NMR spectrum for crystalline Form I atorvastatin hydrate.
    Figure 00120001
    Carbon Atom Assignment and Chemical Shift for Form I Atorvastatin hydrate
    Assignment (7 kHz)Chemical Shift
    C12 or C25182.8
    C12 or C25178.4
    C16166.7 (broad) and 159.3
    Aromatic Carbons
    C2-C5, C13-C18, C19-C24, C27-C32137.0
    134.9
    131.1
    129.5
    127.6
    123.5
    120.9
    118.2
    113.8
    C8,C1073.1
    70.5
    68.1
    64.9
    Methylene Carbons
    C6, C7, C9, C1147.4
    41.9
    40.2
    C3326.4
    25.2
    C3421.3




..................
http://www.google.co.in/patents/US7834195
EXAMPLE 1 Preparation of atorvastatin calcium propylene glycol solvate under anhydrous conditions
Atorvastatin calcium (5 g) was dissolved in racemic propylene glycol followed by the addition of 7 parts of ethyl acetate. The resulting mixture was warmed to 55-60° C. and stirred for 8-10 hours to afford a white suspension. The suspension was cooled to 20-25° C. and filtered to provide 3.3 g of atorvastatin calcium propylene glycol solvate after drying under vacuum at 50-60° C. Propylene glycol content: 6% by NMR.
Isopropyl acetate and methyl, isobutyl ketone (MIBK) can also be used in the example 1 procedure.
The DSC and IR of the solvate made in this example is shown in FIGS. 1 and 2, respectively.
1H-NMR(DMSO-d6): δ 9.82 (s, 1H), 7.51 (ad, J=8.0 Hz, 2H), 7.33-7.11 (m, 6H), 7.08-6.95 (m, 6H), 5.93 (bs, 1H), 4.76 (bs, 1H), 4.65-4.33 (m, 1H), 4.09-3.85 (m, 1H), 3.84-3.68 (m, 2H), 3.62-3.44 (m, 1.5H), 3.30-3.09 (m, 2H), 2.08 (dd, J=15.4, 3.7 Hz), 1.97 (dd, J=15.3, 8.0 Hz), 1.71-1.50 (m, 2H), 1.50-1.31 (m, 7H), 1.30-1.11 (m, 1H), 1.00 (d, J=6.3 Hz, 1.5H).




.........................................................

http://www.google.st/patents/US20040054193




urther, the present invention is directed to crystalline Form V atorvastatin and hydrates thereof characterized by the following solid-state 13C nuclear magnetic resonance (ssNMR) spectrum wherein chemical shift is expressed in parts per million:
AssignmentChemical Shift
C12 or C25185.7
C12 or C25176.8
C16166.9
Aromatic Carbons138.7
C2-C5, C13-C18,136.3
C19-C24, C27-C32
133.0
128.4
122.0
117.0
116.3
C8, C1068.0
Methylene Carbons43.1
C6, C7, C9, C11
C3325.6
C3419.9
[0017] Additionally, the present invention is directed to crystalline Form V atorvastatin and hydrates thereof characterized by the following Raman spectrum having peaks expressed in cm−1:

3062
1652
1604
1528
1478
1440
1413
1397
1368
1158
1034
1001
825
245
224
130
....................................











DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE



Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK
Join me on twitterFollow amcrasto on Twitter     
Join me on google plus Googleplus

 amcrasto@gmail.com






DACCA, BANGLADESH

Map of dhaka city

Image result for DACCA, BANGLADESH











Farmer Harvesting Jute, Tangail,Dhaka, Bangladesh Photographic Print



////////////